Oral cancer test gets UK boost:
This article was originally published in Clinica
Executive Summary
Zila's UK licensee Stafford-Miller, a division of Block Drug, is launching a marketing campaign for Zila's OraTest oral cancer detection system. The five-minute mouth-rinse for squamous cell carcinoma is known as OraScreen in the UK. Stafford-Miller is aiming the campaign at dentists in general practice. The product is available or approved in Australia, Canada, Taiwan, Hungary, Bermuda and other countries. FDA approval is pending.